Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hesham Al‐Sallami"'
Autor:
Adeladlew Kassie Netere, Tony Hughes, Anna‐Marie Babey, Martin Hawes, Janet Mifsud, John P. Kelly, Willmann Liang, Mark Hernandez, Kelly Karpa, Hesham Al‐Sallami, Lynette B. Fernandes, Patrik Aronsson, Carolina Restini, Fabiana Caetano Crowley, Elvan Djouma, Tina Hinton, Johnson J. Liu, Fatima Mraiche, Paul J. White
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 5, Pp n/a-n/a (2024)
Abstract The Core Concepts of Pharmacology (CCP) initiative is developing educational resources to transform pharmacology education into a concept‐based approach. This study evaluated the quality of global educator‐created MCQs in generating item
Externí odkaz:
https://doaj.org/article/da8f2fe3a73047f88b55eabb5014f983
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/6a12147816714207a202f0789b29678d
Autor:
Maimuna Majimbi, Emily Brook, Peter Galettis, Edward Eden, Hani Al-Salami, Armin Mooranian, Hesham Al-Sallami, Virginie Lam, John C L Mamo, Ryusuke Takechi
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0243858 (2021)
BackgroundCannabidiol (CBD) confers therapeutic effects in some neurological disorders via modulation of inflammatory, oxidative and cell-signalling pathways. However, CBD is lipophilic and highly photooxidative with low oral bioavailability in plasm
Externí odkaz:
https://doaj.org/article/058676ea48c849268a27fc0338581c06
Autor:
Jully Gogoi-Tiwari, Vincent Williams, Charlene Babra Waryah, Paul Costantino, Hani Al-Salami, Sangeetha Mathavan, Kelsi Wells, Harish Kumar Tiwari, Nagendra Hegde, Shrikrishna Isloor, Hesham Al-Sallami, Trilochan Mukkur
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170668 (2017)
BACKGROUND:Biofilm formation by Staphylococcus aureus is an important virulence attribute because of its potential to induce persistent antibiotic resistance, retard phagocytosis and either attenuate or promote inflammation, depending upon the diseas
Externí odkaz:
https://doaj.org/article/95c6201ac4ca43c4917c5c7e3d89744b
Publikováno v:
British Journal of Clinical Pharmacology. 88:5348-5358
Current enoxaparin dosing guidelines in children are based on total body weight. This is potentially inappropriate in obese children as it may overestimate the drug clearance. Current evidence suggests that obese children may require lower initial do
Aim: Renal function is an important covariate to describe variability in clearance of renally eliminated drugs. Estimating glomerular filtration rate (GFR) should account for differences in size, age and body composition consistently when using GFR t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38357f4a24bdfb18418c5da94708e8f4
https://doi.org/10.22541/au.164668347.77693963/v1
https://doi.org/10.22541/au.164668347.77693963/v1
Publikováno v:
Clinical pharmacokinetics. 60(4)
Unfractionated heparin (UFH) dosing and monitoring guidelines for children are often extrapolated from adult data. This practice is suboptimal given the inherent differences in haemostatic maturation and drug handling in children compared with adults
Autor:
Hesham, Al-Sallami, Sarah, Jordan, Ruth, Ferguson, Natalie, Medlicott, John, Schollum, Stephen, Duffull
Publikováno v:
The New Zealand medical journal. 123(1313)
To assess the prescribing practice of enoxaparin in comparison to dosing guidelines.A prospective observational chart review of patients who received enoxaparin for the treatment of thrombosis at Dunedin Public Hospital between August 2007 and Januar
Publikováno v:
The New Zealand medical journal. 121(1285)
To determine the incidence of bleeding associated with the use of enoxaparin in NSTEACS at Dunedin Public Hospital (DPH) and to identify bleeding risk factors in this patient group.A case-control retrospective review of clinical notes was undertaken.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::34aa5d9cc6c27b911d5a734726f97936
http://www.scopus.com/inward/record.url?eid=2-s2.0-84867873216&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84867873216&partnerID=MN8TOARS